MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable and tailored medicines.
Location: Netherlands, South Holland, Oegstgeest
Employees: 51-200
Phone: +31 85 888 3161
Total raised: $25.2M
Founded date: 2013
Investors 5
| Date | Name | Website |
| - | Merieux De... | merieux-pa... |
| - | Zeeuws Inv... | zeeuwsinve... |
| - | BioHealth ... | biohealthi... |
| - | Aglaia Onc... | aglaia-onc... |
| - | Korys | korys.be |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.04.2018 | Series B | $20M | - |
| 08.10.2014 | - | $5.2M | - |
Mentions in press and media 6
| Date | Title | Description |
| 10.08.2026 | Deployable Energy Received Investment From Solaris Energy Infrastructure | Deployable Energy, a Houston, Texas-based provider of a deployable microreactor technology platform for critical energy infrastructure, received an equity investment from Solaris Energy Infrastructure, Inc. (NYSE: SEI). The amount of the de... |
| 10.08.2026 | WashWise Raises $1.2M in Pre-Seed Funding | WashWise, a NYC-based provider of a clothing care platform, raised $1.2M in Pre-Seed financing through a SAFE round. The round was led by FJ Labs, Singh Capital, Alex Jekowsky, Jack Abraham, Brian Tate, Gigi Howard, Nina Farran, Mia Tonelli... |
| 12.06.2026 | Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 12, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ther... |
| 17.12.2021 | Inventia Life Science raises $25M, launches ‘RASTRUM’ 3D bioprinting technology in the U.S. | Australian 3D bioprinting specialist Inventia Life Science has announced the closure of a Series B funding round that has seen it raise $25 million (USD). Led by Blackbird Ventures and supported by long-term backer Skip Capital, the investm... |
| 11.04.2018 | Mimetas Secures $20M in Series B Financing | Mimetas, a Leiden, the Netherlands, and Gaithersburg, USA-based developer of organ-on-a-chip products and tissue models, secured $20.5m in Series B financing. Investors included European Life Sciences Growth Fund (ELSGF, Singapore), Aglaia ... |
| 08.10.2014 | Mimetas Raises $5.2M in Funding | Mimetas B.V., a Leiden, The Netherlands-based developer of organ-on-a-chip technology, raised $5.2m in funding. Backers included Zeeuws Investerings Fonds (ZIF) and Participatiemaatschapij Oost Nederland (PPM Oost), which joined forces with... |